Results 111 to 120 of about 1,215 (173)
Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas. [PDF]
Endocr ConnectAraujo-Castro M, Biagetti B, Menéndez E, Novoa-Testa I, Cordido F, Rodríguez Berrocal V, Pascual-Corrales E, Guerrero-Pérez F, Vicente A, García-Centeno R, González L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Tenorio Jimenéz C, Abellán-Galiana P, Venegas E, González-Molero I, Iglesias P, Blanco C, Vidal-Ostos De Lara F, de Miguel Novoa MP, López-Mezquita Torres E, Hanzu F, Lamas C, Aznar Rodríguez S, Aulinas A, Recio JM, Aviles-Pérez MD, Sampedro Núñez MA, Camara R, Paja Fano M, Fajardo C, Cardoso L, Marques P, Martínez-Sáez E, Ruz-Caracuel I, Marazuela M, Puig-Domingo M. +43 moreeuropepmc +1 more sourceAuthor Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. [PDF]
NatureSkoulidis F, Araujo HA, Do MT, Qian Y, Sun X, Cobo AG, Le JT, Montesion M, Palmer R, Jahchan N, Juan JM, Min C, Yu Y, Pan X, Arbour KC, Vokes N, Schmidt ST, Molkentine D, Owen DH, Memmott R, Patil PD, Marmarelis ME, Awad MM, Murray JC, Hellyer JA, Gainor JF, Dimou A, Bestvina CM, Shu CA, Riess JW, Blakely CM, Pecot CV, Mezquita L, Tabbó F, Scheffler M, Digumarthy S, Mooradian MJ, Sacher AG, Lau SCM, Saltos AN, Rotow J, Johnson RP, Liu C, Stewart T, Goldberg SB, Killam J, Walther Z, Schalper K, Davies KD, Woodcock MG, Anagnostou V, Marrone KA, Forde PM, Ricciuti B, Venkatraman D, Van Allen EM, Cummings AL, Goldman JW, Shaish H, Kier M, Katz S, Aggarwal C, Ni Y, Azok JT, Segal J, Ritterhouse L, Neal JW, Lacroix L, Elamin YY, Negrao MV, Le X, Lam VK, Lewis WE, Kemp HN, Carter B, Roth JA, Swisher S, Lee R, Zhou T, Poteete A, Kong Y, Takehara T, Paula AG, Parra Cuentas ER, Behrens C, Wistuba II, Zhang J, Blumenschein GR, Gay C, Byers LA, Gibbons DL, Tsao A, Lee JJ, Bivona TG, Camidge DR, Gray JE, Leighl NB, Levy B, Brahmer JR, Garassino MC, Gandara DR, Garon EB, Rizvi NA, Scagliotti GV, Wolf J, Planchard D, Besse B, Herbst RS, Wakelee HA, Pennell NA, Shaw AT, Jänne PA, Carbone DP, Hellmann MD, Rudin CM, Albacker L, Mann H, Zhu Z, Lai Z, Stewart R, Peters S, Johnson ML, Wong KK, Huang A, Winslow MM, Rosen MJ, Winters IP, Papadimitrakopoulou VA, Cascone T, Jewsbury P, Heymach JV. +130 moreeuropepmc +1 more sourceValidation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors.
J Clin Endocrinol MetabAraujo-Castro M, Menéndez Torre E, Lozano-Aida C, García-Centeno R, González Fernández L, Idrobo C, Achote-Rea E, Irigaray Echarri A, Rodríguez-Argulló MDM, Paja M, Guerrero-Pérez F, Castaño JP, Dolores Ollero García M, Novo-Rodríguez C, Tenorio-Jimenéz C, Villar-Taibo R, Bernabeu I, Díaz-López E, Calatayud M, Alvarez-Escola C, Martín Rojas-Marcos P, Recio-Córdova JM, Aulinas A, Asla Roca Q, Aviles MD, López Mezquita E, Fernández-Argüeso M, González Molero I, Ruz-Caracuel I, Aldecoa I, García J, Martínez-Sáez E, Hanzu F, Marazuela M, Puig-Domingo M, Biagetti B. +35 moreeuropepmc +1 more sourceUse of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects. [PDF]
Diabetes TherVázquez LA, Tofé-Povedano S, Bellido-Guerrero D, Botella-Serrano M, Soto-González A, Mezquita-Raya P, Delgado E, Fajardo-Montañana C, Morales-Portillo C, Causanilles A, Rubio-de Santos M, Romera I, Jódar-Gimeno E. +12 moreeuropepmc +1 more source